SynSysNet: integration of experimental data on synaptic protein-protein interactions with drug-target relations

被引:33
|
作者
von Eichborn, Joachim [1 ]
Dunkel, Mathias [1 ]
Gohlke, Bjoern O. [1 ]
Preissner, Sarah C. [1 ]
Hoffmann, Michael F. [1 ]
Bauer, Jakob M. J. [1 ]
Armstrong, J. D. [2 ]
Schaefer, Martin H. [3 ]
Andrade-Navarro, Miguel A. [3 ]
Le Novere, Nicolas [4 ]
Croning, Michael D. R. [5 ,6 ]
Grant, Seth G. N. [5 ,6 ]
van Nierop, Pim [7 ]
Smit, August B. [7 ]
Preissner, Robert [1 ]
机构
[1] Charite, Inst Physiol, Struct Bioinformat Grp, D-13125 Berlin, Germany
[2] Sch Informat, Inst Neural Computat, Edinburgh EH8 9AB, Midlothian, Scotland
[3] Max Delbruck Ctr Mol Med, Computat Biol Grp, D-13125 Berlin, Germany
[4] Babraham Inst, Cambridge CB22 3AT, England
[5] Univ Edinburgh, Ctr Clin Brain Sci, Genes Cognit Programme, Edinburgh EH16 4SB, Midlothian, Scotland
[6] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh EH16 4SB, Midlothian, Scotland
[7] Vrije Univ Amsterdam, Ctr Neurogen, Dept Mol & Cellular Neurobiol, NL-1081 HV Amsterdam, Netherlands
基金
英国生物技术与生命科学研究理事会;
关键词
DISEASES;
D O I
10.1093/nar/gks1040
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We created SynSysNet, available online at http://bioinformatics.charite.de/synsysnet, to provide a platform that creates a comprehensive 4D network of synaptic interactions. Neuronal synapses are fundamental structures linking nerve cells in the brain and they are responsible for neuronal communication and information processing. These processes are dynamically regulated by a network of proteins. New developments in interaction proteomics and yeast two-hybrid methods allow unbiased detection of interactors. The consolidation of data from different resources and methods is important to understand the relation to human behaviour and disease and to identify new therapeutic approaches. To this end, we established SynSysNet from a set of similar to 1000 synapse specific proteins, their structures and small-molecule interactions. For two-thirds of these, 3D structures are provided (from Protein Data Bank and homology modelling). Drug-target interactions for 750 approved drugs and 50 000 compounds, as well as 5000 experimentally validated protein-protein interactions, are included. The resulting interaction network and user-selected parts can be viewed interactively and exported in XGMML. Approximately 200 involved pathways can be explored regarding drug-target interactions. Homology-modelled structures are downloadable in Protein Data Bank format, and drugs are available as MOL-files. Protein-protein interactions and drug-target interactions can be viewed as networks; corresponding PubMed IDs or sources are given.
引用
收藏
页码:D834 / D840
页数:7
相关论文
共 50 条
  • [41] Computational prediction of novel protein-protein interactions in the post synaptic density
    Bar-Shira, O.
    Chechik, G.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2013, 51 : S14 - S14
  • [42] Protein kinase inhibitors highlight the complexities of drug-target non-covalen interactions
    Engh, R.
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2008, 22 (03) : 772 - 777
  • [43] SYNAPTIC PROTEIN-PROTEIN INTERACTIONS AS POTENTIAL ALCOHOL TARGETS IN MOUSE CORTEX
    Gorini, G.
    Ponomareva, O.
    Roberts, A. J.
    Mayfield, R. D.
    JOURNAL OF NEUROCHEMISTRY, 2011, 118 : 218 - 219
  • [44] GluN1 Hypomorph Disrupts Synaptic Protein-Protein Interactions
    Funk, Adam
    Labilloy, Guillaume
    Mielnik, Catharine
    Meeks, Rebekka
    Greis, Ken
    Meller, Jarek
    Ramsey, Amy
    McCullumsmith, Robert
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S229 - S230
  • [45] Information integration of protein-protein interactions as essential tools for immunomics
    Montanez, Raul
    Navas-Delgado, Ismael
    Medina, Miguel Angel
    Aldana-Montes, Jose F.
    Sanchez-Jimenez, Francisca
    CELLULAR IMMUNOLOGY, 2006, 244 (02) : 84 - 86
  • [46] MSPEDTI: Prediction of Drug-Target Interactions via Molecular Structure with Protein Evolutionary Information
    Wang, Lei
    Wong, Leon
    Chen, Zhan-Heng
    Hu, Jing
    Sun, Xiao-Fei
    Li, Yang
    You, Zhu-Hong
    BIOLOGY-BASEL, 2022, 11 (05):
  • [47] Current Experimental Methods for Characterizing Protein-Protein Interactions
    Zhou, Mi
    Li, Qing
    Wang, Renxiao
    CHEMMEDCHEM, 2016, 11 (08) : 738 - 756
  • [48] Utilization of macrocyclic peptides to target protein-protein interactions in cancer
    Yang, Jiawen
    Zhu, Qiaoliang
    Wu, Yifan
    Qu, Xiaojuan
    Liu, Haixia
    Jiang, Biao
    Ge, Di
    Song, Xiaoling
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [49] Stabilized Helical Peptides: A Strategy to Target Protein-Protein Interactions
    Klein, Mark A.
    ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (08): : 838 - 839
  • [50] A computational approach for predicting drug-target interactions from protein sequence and drug substructure fingerprint information
    Li, Yang
    Liu, Xiao-zhang
    You, Zhu-Hong
    Li, Li-Ping
    Guo, Jian-Xin
    Wang, Zheng
    INTERNATIONAL JOURNAL OF INTELLIGENT SYSTEMS, 2021, 36 (01) : 593 - 609